1133229-30-7
1133229-30-7
Chemical Structure
Levetiracetam-d6 (ring-d6)
Synonym(s): UCB L059-d6 (ring-d6)
- CAS No.: 1133229-30-7
- Formula:C8H8D6N2O2
- Molecular Weight:176.25
IUPAC Name: (S)-2-(2-oxopyrrolidin-1-yl-3,3,4,4,5,5-d6)butanamide
InChIKey: HPHUVLMMVZITSG-QXMLZOKMSA-N
SMILES: NC([C@@H](N1C(C([2H])([2H])C([2H])([2H])C1([2H])[2H])=O)CC)=O
Biological Activity: Levetiracetam-d6 (ring-d6) can be used as internal standard for the determination of Levetiracetam (HY-B0106) content in whole blood[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Levetiracetam-d6 (ring-d6) | 98.70% | Levetiracetam-d6 (ring-d6) can be used as internal standard for the determination of Levetiracetam (HY-B0106) content in whole blood. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levetiracetam (Standard) | 99.96% | Levetiracetam (Standard) is the analytical standard of Levetiracetam. This product is intended for research and analytical applications. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levetiracetam-d6 | Levetiracetam-d6 is the deuterium labeled Levetiracetam. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levetiracetam | 99.98% | Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levetiracetam-d3 | Levetiracetam-d3 is the deuterium labeled Levetiracetam. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
